- cafead Mar 11, 2024 at 05:12: PM
via A pair of setbacks to drugs for Alzheimer's disease and ALS on Friday served as another reminder that widely touted treatments for desperate patients aren't necessarily a sure thing.
Why it matters: Drugs are increasingly judged on the probability they'll work instead of real-world clinical results — often with energetic lobbying by patient advocacy groups.
article source
Why it matters: Drugs are increasingly judged on the probability they'll work instead of real-world clinical results — often with energetic lobbying by patient advocacy groups.
article source